133 results
Page 6 of 7
8-K
EX-10.1
sm1gr9yzq6wa
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
8-K
EX-99.3
qnsp68xl25db04nz
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-99.3
flar0hmr0vgipf2i
8 Jan 21
Business combination disclosure
7:02am
425
EX-10.1
tjmor4qt7qk n1e0
8 Jan 21
Business combination disclosure
7:02am
425
EX-2.1
xgim7w ngzk7q120g4xb
8 Jan 21
Business combination disclosure
7:02am
DEF 14A
kkac1q28x 4tw
4 Dec 20
Definitive proxy
5:23pm
10-K
ft3 aw2ymbm8i
24 Mar 20
Annual report
12:00am
10-Q
xezx q5jv
7 Aug 19
Quarterly report
4:32pm
8-K
EX-99.1
ygt6qha5dn6
30 May 19
GX Acquisition Corp. Index to Financial Statement
4:11pm
8-K
EX-99.2
b574g0wefys
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-1.1
ean9 d3fb4ma5oai4e
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-10.3
ssnf5a2 rii6p
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-10.2
panbhkfh
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-99.1
ijgq8beksb7
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-99.2
2mxrecwrm yy
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-1.1
bfrnjs4t
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm